NBIX - Company ID 0000914475
The table below shows NEUROCRINE BIOSCIENCES INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $713.00M | $233.00M | $251.10M | $262.90M | $340.80M | $187.10M |
| Short-term investments | - | - | - | - | $370.50M | $613.90M |
| Receivables | $686.80M | $479.10M | - | $350.00M | $185.50M | $157.10M |
| Inventory | $69.00M | $57.40M | $38.30M | $35.10M | $30.50M | $28.00M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.52B |
| $1.72B |
| $1.61B |
| $1.45B |
| $972.80M |
| $1.02B |
| Property, plant & equipment | $89.80M | $82.60M | $70.80M | $58.60M | $58.60M | $44.60M |
| Goodwill | - | $5.70M | $5.80M | $5.40M | - | - |
| Total assets | $4.63B | $3.72B | $3.25B | $2.37B | $2.07B | $1.73B |
| Accounts payable | - | - | - | - | - | - |
| Total current liabilities | $743.40M | $507.70M | $654.80M | $537.70M | $245.80M | $186.50M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.38B | $1.13B | $1.02B | $660.90M | $698.50M | $608.50M |
| Retained earnings | $447.70M | $29.20M | -$157.10M | -$406.80M | -$635.80M | -$725.40M |
| Total equity | $3.25B | $2.59B | $2.23B | $1.71B | $1.37B | $1.13B |